News
The acquisition – which will see MSD pay $107 for each American Depository Share (ADS) in UK-headquartered Verona – is the ...
Merck to acquire respiratory drug maker, Verona Pharma for $10 billion: Rahway, New Jersey Thursday, July 10, 2025, 09:00 Hrs [IST] Merck, known as MSD outside of the United State ...
Merck, through a subsidiary, will acquire Verona Pharma for a total transaction value of approximately $10 billion.
British American Tobacco ( NYSE: BTI) was noted to have a strong balance sheet and rich cash returns, while room for improvement with margins is seen. In terms of valuation, British American Tobacco ( ...
18h
Irish Examiner on MSNMerck closing on $10bn deal for respiratory drugmaker VeronaMerck is closing in on a $10bn (€8.5bn) deal to acquire respiratory drugmaker Verona Pharma, the Financial Times reported.
Silver Bullet Mines Corp. (TSXV: SBMI) (OTCQB: SBMCF) ('SBMI' or 'the Company') is pleased to announce it has signed back a ...
Olorofim, a novel antifungal agent, shows efficacy and tolerability in patients with invasive fungal diseases with limited ...
Rahway, New Jersey Wednesday, July 9, 2025, 13:00 Hrs [IST] ...
The deal for CARGO, which remains relatively well funded despite its troubles, comes with a contingent value right (CVR) that ...
RAHWAY, N.J. & RALEIGH, N.C., July 09, 2025--Merck (NYSE: MRK), known as MSD outside of the United States and Canada, and Verona Pharma plc (Nasdaq: VRNA) ("Verona Pharma"), a biopharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results